Search - tctmd.com

Displaying 721 - 740 of 1504

Sort: Relevancy | Date

Presentation TCT 2019

Complex Aortoiliac Occlusive Disease: Achieving Differentiated Performance Through Advanced Technology

Presenter: Ehrin Armstrong

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: How is it Different?

Presenter: Melvin Lobo

September 27, 2019

Presentation TCT 2019

Case 3: Interventional Treatment of Acute Pulmonary Emboli

Presenter: Gregory Piazza

September 26, 2019

Presentation TCT 2019

Case 2: Interventional Treatment of Acute Pulmonary Emboli

Presenter: Andrew Klein

September 26, 2019

Presentation TCT 2019

Case 1: Interventional Treatment of Acute Pulmonary Emboli

Presenter: Philip Green

September 26, 2019

Presentation TCT 2019

Utility and Risks of Vena Cava Filters to Prevent PE

Presenter: Riyaz Bashir

September 26, 2019

Presentation TCT 2019

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Presenter: Rebecca Ward

September 26, 2019

Presentation TCT 2019

Catheter-Directed Therapy for Acute PE II: Indications, Options, Outcomes

Presenter: Thomas Tu

September 26, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Presenter: Jay Giri

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

PERT: Why and How

Presenter: Robert Lookstein

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Diagnosing Pulmonary Embolism: A Practical Approach

Presenter: Ido Weinberg

September 26, 2019

Presentation TCT 2019

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Presenter: Herbert Aronow

September 26, 2019

Advertisement

Complex Aortoiliac Occlusive Disease: Achieving Differentiated Performance Through Advanced Technology

Clinical Evaluation: Peregrine Results to Date

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Alcohol-Mediated Renal Denervation: How is it Different?

Case 3: Interventional Treatment of Acute Pulmonary Emboli

Case 2: Interventional Treatment of Acute Pulmonary Emboli

Case 1: Interventional Treatment of Acute Pulmonary Emboli

Utility and Risks of Vena Cava Filters to Prevent PE

Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal

Catheter-Directed Therapy for Acute PE II: Indications, Options, Outcomes

Potential Study Designs to Address the Mortality Safety Signal

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

PERT: Why and How

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Diagnosing Pulmonary Embolism: A Practical Approach

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content